PuSH - Publikationsserver des Helmholtz Zentrums München

Pollastri, A. ; Kovacs, P.* ; Keller, M.

Circulating cell-free DNA in metabolic diseases.

J. Endocr. Soc. 9:bvaf006 (2025)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Metabolic diseases affect a consistent part of the human population, leading to rising mortality rates. This raises the need for diagnostic tools to monitor the progress of these diseases. Lately, circulating cell-free DNA (cfDNA) has emerged as a promising biomarker for various metabolic diseases, including obesity, type 2 diabetes, and metabolic-associated fatty liver disease. CfDNA is released from apoptotic and necrotic cells into the bloodstream and other body fluids, and it retains various molecular signatures of its tissue of origin. Thus, cfDNA load and composition can reflect tissue pathologies and systemic metabolic dysfunctions. In addition to its potential as a diagnostic biomarker, interest in cfDNA derives from its recently discovered role in adipose tissue inflammation in obesity. This review discusses detection methods and clinical significance of cfDNA in metabolic diseases.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
Schlagwörter Mafld ; Cell-free Dna ; Diabetes ; Epigenetics ; Obesity; Cancer-patients; Plasma; Death; Serum; Inflammation; Obesity; Origin
ISSN (print) / ISBN 2472-1972
e-ISSN 2472-1972
Zeitschrift Journal of the Endocrine Society
Quellenangaben Band: 9, Heft: 2, Seiten: , Artikelnummer: bvaf006 Supplement: ,
Verlag Endocrine Society
Verlagsort 2055 L St Nw, Suite 600, Washington, Dc 20036 Usa
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
Förderungen Deutsches Zentrum fur Diabetesforschung (DZD)
Deutsche Diabetes Gesellschaft
Deutsche Forschungsgemeinschaft for a Collaborative Research Center